Bulletin
Investor Alert

Topics

Flu

Video

WSJ Opinion: Was Pausing Johnson & Johnson's Covid Vaccine a Good Idea?

  • WSJ Opinion: Was Pausing Johnson & Johnson's Covid Vaccine a Good Idea? WSJ Opinion: Was Pausing Johnson & Johnson's Covid Vaccine a Good Idea? 6:04
    WSJ Opinion: The Making of an Asian-American Hate Narrative WSJ Opinion: The Making of an Asian-American Hate Narrative 4:25
    WSJ Opinion: Joe Biden's Super State WSJ Opinion: Joe Biden's Super State 5:42
    WSJ Opinion: How the U.S. Fast-Tracked Covid Vaccines WSJ Opinion: How the U.S. Fast-Tracked Covid Vaccines 8:16
10:54 a.m. Nov. 9, 2020 - By Cody Willard
A new normal is on the horizon for investors — but what does that look like? Coronavirus treatments will be a game changer. But they won’t change the trajectory of innovative companies making their way through the world Coronavirus treatments will be a game changer. But they won’t change the trajectory of innovative companies making their way through the world.
5:34 a.m. Oct. 3, 2020 - By Paul Brandus
Trump tests positive for coronavirus. At stake: the campaign, the operation of the federal government and the makeup of the Supreme Court The implications of the president’s illness are wide-rangingThe implications of the president’s illness are wide-ranging.
5:57 a.m. Sept. 18, 2020 - By Cody Willard
You’ve heard of bulls and bears in the stock market. Don’t be a chicken Investors need to avoid being followers during times of market euphoria or panicInvestors need to avoid being followers during times of market euphoria or panic.
5:37 a.m. Aug. 15, 2020 - By Ronald D. Fricker Jr.
The ‘excess deaths’ tally in the U.S. is 204,691 in 7 months — so COVID-19 deaths might be undercounted The number of excess deaths exceeds the number attributable to COVID-19 by more than 16,000 peopleThe number of deaths through July 2020 is 8% to 12% higher than it would have been if the coronavirus pandemic had never happened.
4:57 a.m. July 16, 2020 - By Bruce Y. Lee
This new study shows how well a coronavirus vaccine must work before we can stop social distancing A COVID-19 vaccine needs to be much more effective than a flu shotA COVID-19 vaccine needs to be much more effective than a flu shot.
12:34 p.m. July 11, 2020 - By Michael Brush
5 ways to beat the stock market — from a fund manager who’s done this for years These lessons from Amana Growth Fund can make you a better investorThese lessons from Amana Growth Fund can make you a better investor.
8:29 a.m. June 27, 2020 - By Michael Brush
Bad news is punishing stock market investors — here’s how to deal with it As market weakness develops, scale into stocks that get hit the mostAs market weakness develops, scale into stocks that get hit the most.
8:11 a.m. June 20, 2020 - By Michael Brush
Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team If true, any approval may not actually benefit a vaccine company, but instead other parts of the stock marketIf true, any approval may not actually benefit a vaccine company, but instead other parts of the stock market.
4:23 a.m. June 17, 2020 - By Anne Case
The United States of Despair is gripped by two simultaneous pandemics that expose a widening inequality gap While the wealthy few watch their portfolios rise, the poor white and brown majority sees their life expectancy fallBetween rising “deaths of despair” among working-class whites and higher COVID-19 mortality rates among African-Americans, the stunning secular decline in U.S. life expectancy will continue, write Anne Case and Angus Deaton.
4:25 a.m. June 15, 2020 - By Peter Morici
Socialism tempts Millennials as capitalism struggles with COVID-19 Moderates in both political parties face an unsettling rebellion at the ballot boxLiving with our system’s broken promises and depression-like conditions will make young people even more receptive to the ideological heirs of Sen. Bernie Sanders.
5:29 a.m. June 13, 2020 - By Michael Brush
Warren Buffett made a smart move by buying more shares of Liberty Sirius XM — here’s why you might want to do the same Buffett and his team made a mistake by selling airlines recently, but they haven’t lost their touchBuffett and his team made a mistake by selling airlines recently, but they haven’t lost their touch.
4:58 a.m. June 8, 2020 - By Jory Brinkerhoff
That summer flu might be Lyme disease, not coronavirus — and you don’t want that, either Delaying treatment can lead to severe, potentially debilitating symptomsDelaying treatment can lead to severe, potentially debilitating symptoms.
6:11 a.m. May 19, 2020 - By Robert Skidelsky
Why governments can’t tell the truth about opening up: that many will die They cannot admit that we’ve given up on beating the coronovirus, and that herd immunity is now the objectiveGovernments cannot openly admit that the “controlled easing” of COVID-19 lockdowns in fact means controlled progress toward so-called herd immunity to the virus and an unacceptable number of deaths.
2:00 a.m. May 18, 2020 - By Peter Morici
Washington should back off and let the governors manage the crisis Progressives will be stymied in their efforts to expand big governmentGovernors are best positioned to weigh tradeoffs between impositions on personal liberty associated with social distancing, testing, tracking and quarantining, and the risks of a second wave of infections.
11:40 a.m. May 11, 2020 - By Michael Brush
Biotechnology experts who understand both science and investing are skeptical of the stock market’s strength The pandemic’s damage to the economy, and investing markets, may be long-lasting and worse than expected, they sayThe pandemic’s damage to the economy, and investing markets, may be long-lasting and worse than expected, they say.
7:40 a.m. May 11, 2020 - By George Soros
George Soros: ‘I do not think anybody knows how capitalism will evolve’ amid the coronavirus pandemic The investor talks about COVID-19, the possible breakup of the European Union and the weakened power of Chinese President Xi JinpingThe investor talks about COVID-19, the possible breakup of the European Union and the weakened power of Chinese President Xi Jinping.
2:00 a.m. May 11, 2020 - By Peter Morici
The coronavirus won’t kill globalization China may end up with fewer deaths, less economic damage than the U.S. or EuropeThe coronavirus lays bare the terrible dangers of globalization without adequate safeguards, but it hardly summons its demise.
6:50 a.m. May 5, 2020 - By Bruce Y. Lee
Treating a typical coronavirus infection is four times the cost of a case of the flu The median cost of a coronavirus hospitalization is $14,366The median cost of a coronavirus hospitalization is $14,366.
10:17 a.m. May 4, 2020 - By William A. Haseltine
Can the U.S. handle the second wave of COVID-19 coming our way? We’re failing to reduce the number of coronavirus infections before the next peak hitsThe United States is not limiting COVID-19 infections enough to avoid a serious second wave of the pandemic later this year.
2:07 a.m. May 1, 2020 - By Jurica Dujmovic
How China used robots, drones and artificial intelligence to control the spread of the coronavirus It’s true that China instituted harsh restrictive measures. Left out of the story has been Chinese-designed technologyIt’s true that China instituted harsh restrictive measures. Left out of the story has been Chinese-designed technology.
5:30 a.m. April 25, 2020 - By Geoffrey Joyce
Are we overreacting to the coronavirus? Let’s do the math Is the economic cost of COVID-19 $150 billion? Or $5.6 trillion?Is the economic cost of COVID-19 $150 billion? Or $5.6 trillion?
5:50 a.m. April 23, 2020 - By Joseph E. Stiglitz
Should patents come before patients? How drug monopolies hamper the fight against coronavirus COVID-19 pandemic shows the urgency of replacing a monopoly-driven system with one based on cooperation and shared knowledgeDrug monopolies kill, by denying access to life-saving medicines that otherwise would have been available under an alternative system — like the one facilitating the yearly production of the flu vaccine.
Browse topics:

Filter results by

Location

Us (252)

Asia Pacific (45)

Europe (42)

China (36)

Eu (32)

Latin America (9)

Link to MarketWatch's Slice.